Julphar recognized as No. 1 in UAE by IMS

According to IMS Health, Julphar has been ranked the No.1 pharmaceutical manufacturer in UAE for the first quarter of 2017, reflecting a sales growth of 11.5% over the last quarter.
It is the first time the Emirati company reached the first position in the IMS ranking for the UAE market.
“I am so proud of our Julphar UAE’s sales team,” said Dr Maen Al Jayousi, Senior Director for UAE, Oman, Levant, Iraq & business – developed countries. “The team has accomplished a remarkable performance and I would like to highlight their outstanding work, which made it possible for the company to reach the first position in the IMS listing.”
“The IMS recognition shows Julphar’s commitment of achieving his vision to be ranked among the top players in the pharmaceutical industry,” added Dr Rashid Khan, Area Manager for UAE and Oman. “We will keep on working hard and the results we achieved during the first quarter is one step forward towards achieving that goal.”
This website intends to use cookies to improve the site and your experience. By continuing to browse the site you are agreeing to accept our use of cookies. If you require further information and/or do not wish to have cookies placed when using the site, refer to our Cookie Policy.